EUVIMEDEUVIMED entdecken
Open Access

Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence Tomography

Susan LeGendre-McGhee, Photini S Rice, R Andrew Wall, Kyle J Sprute, Ramireddy Bommireddy, Amber M Luttman, Raymond B Nagle, Edward R Abril, Katrina Farrell, Chiu-Hsieh Hsu, Denise J Roe, Eugene W Gerner und 2 weitere

Cancer Growth and Metastasis · 2015

DOI: 10.4137/cgm.s21216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Growth and Metastasis, 2015. Verfasst von Susan LeGendre-McGhee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Arizona, Tucson, AZ, USA. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Optical coherence tomography (OCT) is a high-resolution, nondestructive imaging modality that enables time-serial assessment of adenoma development in the mouse model of colorectal cancer. In this study, OCT was utilized to evaluate the effectiveness of interventions with the experimental antitumor agent α-difluoromethylornithine (DFMO) and a nonsteroidal anti-inflammatory drug sulindac during early [chemoprevention (CP)] and late stages [chemotherapy (CT)] of colon tumorigenesis. Biological endpoints for drug interventions included OCT-generated tumor number and tumor burden. Immunochistochemistry was used to evaluate biochemical endpoints [Ki-67, cleaved caspase-3, cyclooxygenase (COX)-2, β-catenin]. K-Ras codon 12 mutations were studied with polymerase chain reaction-based technique. We demonstrated that OCT imaging significantly correlated with histological analysis of both tumor number and tumor burden for all experimental groups ( P < 0.0001), but allows more accurate and full characterization of tumor number and burden growth rate because of its time-serial, nondestructive nature. DFMO alone or in combination with sulindac suppressed both the tumor number and tumor burden growth rate in the CP setting because of DFMO-mediated decrease in cell proliferation (Ki-67, P < 0.001) and K-RAS mutations frequency ( P = 0.04). In the CT setting, sulindac alone and DFMO/sulindac combination were effective in reducing tumor number, but not tumor burden growth rate. A decrease in COX-2 staining in DFMO/sulindac CT groups (COX-2, P < 0.01) confirmed the treatment effect. Use of nondestructive OCT enabled repeated, quantitative evaluation of tumor number and burden, allowing changes in these parameters to be measured during CP and as a result of CT. In conclusion, OCT is a robust minimally invasive method for monitoring colorectal cancer disease and effectiveness of therapies in mouse models.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancermouse modeloptical coherence tomographysulindacα-difluoromethylornithine

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Arizona, Tucson, AZ, USA.
  • College of Optical Sciences, University of Arizona, Tucson, AZ, USA.
  • University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.
  • Department of Pathology, University of Arizona, Tucson, AZ, USA.
  • Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, USA.
  • Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

LeGendre-McGhee, S., Rice, P. S., Wall, R. A., Sprute, K. J., Bommireddy, R., Luttman, A. M., Nagle, R. B., Abril, E. R., Farrell, K., Hsu, C. H., Roe, D. J., Gerner, E. W., Ignatenko, N. A., & Barton, J. K. (2015). Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence Tomography. Cancer Growth and Metastasis. https://doi.org/10.4137/cgm.s21216

Vancouver

LeGendre-McGhee S, Rice PS, Wall RA, Sprute KJ, Bommireddy R, Luttman AM, et al. Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence Tomography. Cancer Growth and Metastasis. 2015. doi:10.4137/cgm.s21216

BibTeX
@article{LeGendreMcGhee2015,
  author = {LeGendre-McGhee, Susan and Rice, Photini S and Wall, R Andrew and Sprute, Kyle J and Bommireddy, Ramireddy and Luttman, Amber M and Nagle, Raymond B and Abril, Edward R and Farrell, Katrina and Hsu, Chiu-Hsieh and Roe, Denise J and Gerner, Eugene W and Ignatenko, Natalia A and Barton, Jennifer K},
  title = {Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence Tomography},
  journal = {Cancer Growth and Metastasis},
  year = {2015},
  doi = {10.4137/cgm.s21216}
}
Kostenlos starten →